HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffin, N. Articles by Sohaib, S. A. Search for Related Content PubMed PubMed Citation Articles by Griffin, N. Articles by Sohaib, S. A. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Imaging in Metastatic Renal Cell Carcinoma

¹ Department of Diagnostic Imaging, Royal Marsden Hospital, 203 Fulham Rd., London SW3 6JJ, United Kingdom.
² Department of Medical Oncology, Royal Marsden Hospital, London, United Kingdom.

OBJECTIVE. Metastatic disease occurs in a significant percentage of patients with renal cell carcinoma. Recent advances in systemic therapies for metastatic renal cell carcinoma are likely to have a significant effect on the way patients with advanced disease are imaged. These new therapies have shown a significant increase in progression-free survival.

CONCLUSION. Imaging is likely to play an increasing role in the management, diagnosis, and monitoring of response to treatment of metastatic renal cell carcinoma.

Keywords: CT • kidney • renal cell carcinoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S A SOHAIB, G COOK, S D ALLEN, M HUGHES, T EISEN, and M GORE Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer Br. J. Radiol., August 1, 2009; 82(980): 632 - 639. [Abstract] [Full Text] [PDF]